Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Синдром обструктивного апноэ сна: обзор литературы - Научно-практический журнал Cardioсоматика Том 14, №1 (2023)
Синдром обструктивного апноэ сна: обзор литературы
Сурикова Н.А., Глухова А.С. Синдром обструктивного апноэ сна: обзор литературы // CardioСоматика. 2023. Т. 14, № 1. С. 67-76.
DOI: https://doi.org/10.17816/CS321374
DOI: https://doi.org/10.17816/CS321374
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Целью работы было провести анализ и обобщение имеющихся данных по синдрому обструктивного апноэ сна как фактора риска возникновения и утяжеления течения заболеваний сердечно-сосудистой системы. В обзоре представлены материалы отечественных и зарубежных авторов по факторам риска и их профилактике. Для написания статьи использовано 52 различных источника литературы — статьи, опубликованные в международных базах цитирования PubMed (MEDLINE), Scopus, а также опубликованные в РИНЦ фундаментальные исследования, монографии. Отбор данных осуществляли по ключевым словам: «сердечно-сосудистые заболевания», «факторы риска», «артериальная гипертензия», «хроническая сердечная недостаточность», «фибрилляция предсердий», «апноэ». Из анализа исключали материалы, авторство которых не установлено, учебные пособия, околонаучные Интернет-ресурсы, а также публикации, не соответствующие тематике исследования. Сонное апноэ является широко распространённым, но недостаточно часто обнаруживаемым заболеванием среди больных с сердечно-сосудистыми патологиями. Дальнейшее изучение методов диагностики и лечения сонного апноэ является перспективным направлением с точки зрения работы над факторами риска и эффективностью лечения сердечно-сосудистых заболеваний.
Ключевые слова: факторы риска; сердечно-сосудистые заболевания; апноэ, артериальная гипертензия
Keywords: risk factors; cardiovascular diseases; apnea; arterial hypertension
Ключевые слова: факторы риска; сердечно-сосудистые заболевания; апноэ, артериальная гипертензия
________________________________________________
Keywords: risk factors; cardiovascular diseases; apnea; arterial hypertension
Полный текст
Список литературы
1. Пальман А.Д, Аксельрод А.С. Желудочковые нарушения ритма сердца у пациента с синдромом обструктивного апноэ сна и их эффективное немедикаментозное лечение // Альманах клинической медицины. 2021. Т. 49, № 2. С. 165–170. doi: 10.18786/2072-0505-2021-49-031
2. Кантимирова Е.А. Современные методы дифференциальной диагностики центрального и обструктивного апноэ сна // Вестник Клинической больницы № 51. 2012. № 1–2. С. 34–37.
3. Рубина С.С., Макарова И.И. Обструктивное апноэ сна: современный взгляд на проблему // Уральский медицинский журнал. 2021. Т. 20, № 4. С. 85–92.
doi: 10.52420/2071-5943-2021-20-4-85-92
4. Arzt M., Woehrle H., Oldenburg O., et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry // JACC Heart Fail. 2016. Vol. 4, N 2. P. 116–125. doi: 10.1016/j.jchf.2015.09.014
5. Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020 // Российский кардиологический журнал. 2020. Т. 25, № 3. С. 3786. doi: 10.15829/1560-4071-2020-3-3786
6. Евлампиева Л.Г., Ярославская Е.И., Харац В.Е. Взаимосвязь синдрома обструктивного апноэ сна и факторов сердечно-сосудистого риска // Сибирский журнал клинической и экспериментальной медицины. 2021. Т. 36, № 1. С. 58–65. doi: 10.29001/2073-8552-2021-36-1-58-65
7. Yeghiazarians Y., Jneid H., Tietjens J.R., et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association // Circulation. 2021. Vol. 144, N 3. P. e56–e67. doi: 10.1161/CIR.0000000000000988. Erratum in: Circulation. 2022. Vol. 145, N 12. P. e775.
8. Warchol-Celinska E., Prejbisz A., Kadziela J., et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial // Hypertension. 2018. Vol. 72, N 2. P. 381–390. doi: 10.1161/HYPERTENSIONAHA.118.11180
9. Johnson D.A., Thomas S.J., Abdalla M., et al. Association Between Sleep Apnea and Blood Pressure Control Among Blacks // Circulation. 2019. Vol. 139, N 10. P. 1275–1284. doi: 10.1161/CIRCULATIONAHA.118.036675
10. Dempsey J.A., Veasey S.C., Morgan B.J., O’Donnell C.P. Pathophysiology of sleep apnea // Physiol Rev. 2010. Vol. 90, N 1. P. 47–112. doi: 10.1152/physrev.00043.2008
11. Kwon Y., Debaty G., Puertas L., et al. Effect of regulating airway pressure on intrathoracic pressure and vital organ perfusion pressure during cardiopulmonary resuscitation: a non-randomized interventional cross-over study // Scand J Trauma Resusc Emerg Med. 2015. N 23. P. 83. doi: 10.1186/s13049-015-0164-5
12. Tolle F.A., Judy W.V., Yu P.L., Markand O.N. Reduced stroke volume related to pleural pressure in obstructive sleep apnea // J Appl Physiol Respir Environ Exerc Physiol. 1983. Vol. 55, N 6. P. 1718–1724. doi: 10.1152/jappl.1983.55.6.1718
13. Somers V.K., Dyken M.E., Clary M.P., Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea // J Clin Invest. 1995. Vol. 96, N 4. P. 1897–904. doi: 10.1172/JCI118235
14. Sforza E., Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach // Hypoxia (Auckl). 2016. N4:. P. 99–108. doi: 10.2147/HP.S10309
15. Arredondo E., Udeani G., Panahi L., et al. Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know // Cureus. 2021. Vol. 13, N 9. P. e17843. doi: 10.7759/cureus.17843
16. Silveira M.G., Sampol G., Mota-Foix M., et al. Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up // J Clin Sleep Med. 2022. Vol. 18, N 2. P. 597–607. doi: 10.5664/jcsm.9674
17. Martinez-Garcia M.A., Capote F., Campos-Rodriguez F., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial // JAMA. 2013. Vol. 310, N 22. P. 2407–2415. doi: 10.1001/jama.2013.281250
18. Javaheri S., Gottlieb D.J., Quan S.F. Effects of continuous positive airway pressure on blood pressure in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES) // J Sleep Res. 2019. Vol. 29, N 2. P. e12943. doi: 10.1111/jsr.12943
19. Walia H.K., Li H., Rueschman M., et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use // J Clin Sleep Med. 2014. Vol. 10, N 8. P. 835–843. doi: 10.5664/jcsm.3946
20. Deleanu O.C., Oprea C.I., Malaut A.E., et al. Long-term effects of CPAP on blood pressure in non-resistant hypertensive patients with obstructive sleep apnea: A 30 month prospective study // European Respiratory Journal. 2016. N 48. P. PA2082. doi: 10.1183/13993003.congress-2016.PA2082
21. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension // N Engl J Med. 2000. Vol. 342, N 19. P. 1378–1384. doi: 10.1056/NEJM200005113421901
22. O’Connor G.T., Caffo B., Newman A.B., et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study // Am J Respir Crit Care Med. 2009. Vol. 179, N 12. P. 1159–1164. doi: 10.1164/rccm.200712-1809OC
23. Аксенова А.В., Сивакова О.А., Блинова Н.В., и др. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии // Терапевтический архив. 2021. Т. 93, № 9. С. 1018–1029. doi: 10.26442/00403660.2021.09.201007
24. Marin J.M., Agusti A., Villar I., et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension // JAMA. 2012. Vol. 307, N 20. P. 2169–2176. doi: 10.1001/jama.2012.3418
25. Mokhlesi B., Varga A.W. Obstructive Sleep Apnea and Cardiovascular Disease. REM Sleep Matters! // Am J Respir Crit Care Med. 2018. Vol. 197, N 5. P. 554–556. doi: 10.1164/rccm.201710-2147ED
26. Баймуканов А.М., Булавина И.А., Петрова Г.А., и др. Апноэ сна у пациентов с фибрилляцией предсердий // Лечебное дело. 2022. № 2. С. 132–136.
doi: 10.24412/2071-5315-2022-12817
27. Tung P., Levitzky Y.S., Wang R., et al. Obstructive and Central Sleep Apnea and the Risk of Incident Atrial Fibrillation in a Community Cohort of Men and Women // J Am Heart Assoc. 2017. Vol. 6, N 7. P. e004500. doi: 10.1161/JAHA.116.004500
28. Харац В.Е. Проблема ассоциации обструктивного апноэ сна и фибрилляции предсердий в условиях кардиологической практики // Сибирский журнал клинической и экспериментальной медицины. 2022. Т. 37, № 3. С. 41–48. doi: 10.29001/2073-8552-2022-37-3-41-48
29. Остроумова О.Д., Исаев Р.И., Котовская Ю.В., Ткачева О.Н. Влияние лекарственных средств на синдром обструктивного апноэ сна // Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2020. Т. 120, № 9–2. С. 46–54. (In Russ). doi: 10.17116/jnevro202012009146
30. Linz D., McEvoy R.D., Cowie M.R., et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review // JAMA Cardiol. 2018. Vol. 3, N 6. P. 532–540. doi: 10.1001/jamacardio.2018.0095
31. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients // Eur J Heart Failure. 2007. Vol. 9, N 3. P. 251–257. doi: 10.1016/j.ejheart.2006.08.003
32. Sanchez A.M., Germany R., Lozier M.R., et al. Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications // Int J Cardiol Heart Vasc. 2020. N 30. P. 100527. doi: 10.1016/j.ijcha.2020.100527
33. Chen L., Zadi Z.H., Zhang J., et al. Intermittent hypoxia in utero damages postnatal growth and cardiovascular function in rats // J Appl Physiol (1985). 2018. Vol. 124, N 4. P. 821–830. doi: 10.1152/japplphysiol.01066.2016
34. Orban M., Bruce C.J., Pressman G.S., et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure // Am J Cardiol. 2008. Vol. 102, N 11. P. 1557–1561. doi: 10.1016/j.amjcard.2008.07.050
35. Khayat R.N., Abraham W.T., Patt B., et al. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea // Chest. 2008. Vol. 134, N 6. P. 1162–1168. doi: 10.1378/chest.08-0346
36. Javaheri S., Javaheri S. Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions // J Clin Med. 2022. Vol. 11, N12). P. 3458. doi: 10.3390/jcm11123458
37. Gunta S.P., Jakulla R.S., Ubaid A., et al. Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 // Cardiovasc Ther. 2022. N 2022. P. 6006127. doi: 10.1155/2022/6006127
38. O΄Donnell C., O΄Mahony A.M., McNicholas W.T., Ryan S. Cardiovascular manifestations in obstructive sleep apnea: current evidence and potential mechanisms // Polish Arch Internal Med. 2021. Vol. 131, N 6. P. 550–560. doi: 10.20452/pamw.16041
39. Newman S.B., Kundel V., Matsuzaki M., et al. Sleep apnea, coronary artery calcium density, and cardiovascular events: results from the Multi-Ethnic Study of Atherosclerosis // J Clin Sleep Med. 2021. Vol. 17, N 10. P. 2075–2083. doi: 10.5664/jcsm.9356
40. Mooe T., Franklin K.A., Wiklund U., et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease // Chest. 2000. Vol. 117, N 6. P. 1597–1602. doi: 10.1378/chest.117.6.1597
41. Wang X., Zhang Y., Dong Z., et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis // Respir Res. 2018. Vol. 19, N 1. P. 61. doi: 10.1186/s12931-018-0761-8
42. Аксенова А.В., Сивакова О.А., Блинова Н.В., и др. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии // Терапевтический архив. 2021. Т. 93, № 9. С. 1018–1029. doi: 10.26442/004036
43. Бузунов Р.В., Пальман А.Д., Мельников А.Ю., и др. Диагностика и лечение синдрома обструктивного апноэ сна у взрослых. Рекомендации Российского общества сомнологов // Эффективная фармакотерапия. Неврология. Спецвыпуск «Сон и его расстройства». 2018. № 35. С. 34–45.
44. Chung F., Yegneswaran B., Liao P., et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea // Anesthesiology. 2008. Vol. 108, N 5. P. 812–821. doi: 10.1097/ALN.0b013e31816d83e4
45. Fudim M., Shahid I., Emani S., et al. Evaluation and treatment of central sleep apnea in patients with heart failure // Curr Probl Cardiol. 2022. Vol. 47, N 12. P. 101364. doi: 10.1016/j.cpcardiol.2022.101364
46. Tran N.T., Tran H.N., Mai A.T. A wearable device for at-home obstructive sleep apnea assessment: State-of-the-art and research challenges // Front Neurol. 2023. N 14. P. 1123227. doi: 10.3389/fneur.2023.1123227
47. Monda V.M., Gentile S., Porcellati F., et al. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes // Adv Ther. 2022. Vol. 39, N 11. P. 4837–4846. doi: 10.1007/s12325-022-02310-2
48. Бузунов Р.В. Ожирение и синдром обструктивного апноэ во сне: как разорвать порочный круг // Эффективная фармакотерапия. 2020. Т. 16, № 2. С. 30–33.
49. Brulé D., Villano C., Davies L.J., et al. The grapevine (Vitis vinifera) LysM receptor kinases VvLYK1-1 and VvLYK1-2 mediate chitooligosaccharide-triggered immunity // Plant Biotechnol J. 2019. Vol. 17, N 4. P. 812–825. doi: 10.1111/pbi.13017
50. Chang H.P., Chen Y.F., Du J.K. Obstructive sleep apnea treatment in adults // Kaohsiung J Med Sci. 2020. Vol. 36, N 1. P. 7–12. doi: 10.1002/kjm2.12130
51. Горбунова М.В., Бабак С.Л., Малявин А.Г. Современный алгоритм диагностики и лечения кардиоваскулярных и метаболических нарушений у пациентов с обструктивным апноэ сна // Лечебное дело. 2019. № 1. C. 20–29. doi: 10.24411/2071-5315-2019-12086
52. Akashiba T., Inoue Y., Uchimura N., et al. Sleep apnea syndrome (SAS) clinical practice guidelines 2020 // Respir Investig. 2022. Vol. 60, N 1. P. 3–32. doi: 10.1016/j.resinv.2021.08.010
2. Kantimirova EA. Modern methods of differential diagnosis of central and obstructive sleep apnea. Vestnik Klinicheskoi bol'nitsy № 51. 2012;1–2:34–37. (In Russ).
3. Rubina SS, Makarova II. Obstructive sleep apnea: a modern view of the problem. Ural Medical Journal. 2021;20(4):85–92. (In Russ). doi: 10.52420/2071-5943-2021-20-4-85-92
4. Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail. 2016;4(2):116–125. doi: 10.1016/j.jchf.2015.09.014
5. Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ).
doi: 10.15829/1560-4071-2020-3-3786
6. Evlampieva LG, Yaroslavskaya EI, Kharats VE. Relationships between obstructive sleep apnea syndrome and cardiovascular risk factors. The Siberian Journal of Clinical and Experimental Medicine. 2021;36(1):58–65. (In Russ). doi: 10.29001/2073-8552-2021-36-1-58-65
7. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56–e67. doi: 10.1161/CIR.0000000000000988. Erratum in: Circulation. 2022;145(12):e775.
8. Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial. Hypertension. 2018;72(2):381–390. doi: 10.1161/HYPERTENSIONAHA.118.11180
9. Johnson DA, Thomas SJ, Abdalla M, et al. Association Between Sleep Apnea and Blood Pressure Control Among Blacks. Circulation. 2019;139(10):1275–1284. doi: 10.1161/CIRCULATIONAHA.118.036675
10. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47–112. doi: 10.1152/physrev.00043.2008
11. Kwon Y, Debaty G, Puertas L, et al. Effect of regulating airway pressure on intrathoracic pressure and vital organ perfusion pressure during cardiopulmonary resuscitation: a non-randomized interventional cross-over study. Scand J Trauma Resusc Emerg Med. 2015;23:83. doi: 10.1186/s13049-015-0164-5
12. Tolle FA, Judy WV, Yu PL, Markand ON. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(6):1718–1724. doi: 10.1152/jappl.1983.55.6.1718
13. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897–904. doi: 10.1172/JCI118235
14. Sforza E, Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach. Hypoxia (Auckl). 2016;4:99–108. doi: 10.2147/HP.S10309
15. Arredondo E, Udeani G, Panahi L, et al. Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know. Cureus. 2021;13(9):e17843. doi: 10.7759/cureus.17843
16. Silveira MG, Sampol G, Mota-Foix M, et al. Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up. J Clin Sleep Med. 2022;18(2):597–607. doi: 10.5664/jcsm.9674
17. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–2415. doi: 10.1001/jama.2013.281250
18. Javaheri S, Gottlieb DJ, Quan SF. Effects of continuous positive airway pressure on blood pressure in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). J Sleep Res. 2019;29(2):e12943. doi: 10.1111/jsr.12943
19. Walia HK, Li H, Rueschman M, et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med. 2014;10(8):835–843. doi: 10.5664/jcsm.3946
20. Deleanu OC, Oprea CI, Malaut AE, et al. Long-term effects of CPAP on blood pressure in non-resistant hypertensive patients with obstructive sleep apnea: A 30 month prospective study. European Respiratory Journal. 2016;48:PA2082. doi: 10.1183/13993003.congress-2016.PA2082
21. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384. doi: 10.1056/NEJM200005113421901
22. O’Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159–1164. doi: 10.1164/rccm.200712-1809OC
23. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018–1029. (In Russ). doi: 10.26442/00403660.2021.09.201007
24. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–2176. doi: 10.1001/jama.2012.3418
25. Mokhlesi B, Varga AW. Obstructive Sleep Apnea and Cardiovascular Disease. REM Sleep Matters! Am J Respir Crit Care Med. 2018;197(5):554–556.
doi: 10.1164/rccm.201710-2147ED
26. Baimukanov AM, Bulavina IA, Petrova GA, et al. Sleep apnea in patients with atrial fibrillation. Lechebnoe Delo. 2022;2:132–136. (In Russ). doi: 10.24412/2071-5315-2022-12817
27. Tung P, Levitzky YS, Wang R, et al. Obstructive and Central Sleep Apnea and the Risk of Incident Atrial Fibrillation in a Community Cohort of Men and Women. J Am Heart Assoc. 2017;6(7):e004500. doi: 10.1161/JAHA.116.004500
28. Kharats VE. The problem of association between obstructive sleep apnea and atrial fibrillation in cardiology practice. The Siberian Journal of Clinical and Experimental Medicine. 2022;37(3):41–48. (In Russ). doi: 10.29001/2073-8552-2022-37-3-41-48
29. Ostroumova OD, Isaev RI, Kotovskaya YV, Tkacheva ON. Drugs affecting obstructive sleep apnea syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(9–2):46–54. (In Russ). doi: 10.17116/jnevro202012009146
30. Linz D, McEvoy RD, Cowie MR, et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review. JAMA Cardiol. 2018;3(6):532–540. doi: 10.1001/jamacardio.2018.0095
31. Oldenburg O, Lamp B, Faber L, et al. Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Failure. 2007;9(3):251–257. doi: 10.1016/j.ejheart.2006.08.003
32. Sanchez AM, Germany R, Lozier MR, et al. Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications. Int J Cardiol Heart Vasc. 2020;30:100527. doi: 10.1016/j.ijcha.2020.100527
33. Chen L, Zadi ZH, Zhang J, et al. Intermittent hypoxia in utero damages postnatal growth and cardiovascular function in rats. J Appl Physiol (1985). 2018;124(4):821–830. doi: 10.1152/japplphysiol.01066.2016
34. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102(11):1557–1561. doi: 10.1016/j.amjcard.2008.07.050
35. Khayat RN, Abraham WT, Patt B, et al. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea. Chest. 2008;134(6):1162–1168. doi: 10.1378/chest.08-0346
36. Javaheri S, Javaheri S. Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions. J Clin Med. 2022;11(12):3458. doi: 10.3390/jcm11123458
37. Gunta SP, Jakulla RS, Ubaid A, et al. Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022. Cardiovasc Ther. 2022;2022:6006127. doi: 10.1155/2022/6006127
38. O΄Donnell C, O΄Mahony AM, McNicholas WT, Ryan S. Cardiovascular manifestations in obstructive sleep apnea: current evidence and potential mechanisms. Polish Arch Internal Med. 2021;131(6):550–560. doi: 10.20452/pamw.16041
39. Newman SB, Kundel V, Matsuzaki M, et al. Sleep apnea, coronary artery calcium density, and cardiovascular events: results from the Multi-Ethnic Study of Atherosclerosis. J Clin Sleep Med. 2021;17(10):2075–2083. doi: 10.5664/jcsm.9356
40. Mooe T, Franklin KA, Wiklund U, et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest. 2000;117(6):1597–1602. doi: 10.1378/chest.117.6.1597
41. Wang X, Zhang Y, Dong Z, et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis. Respir Res. 2018;19(1):61. doi: 10.1186/s12931-018-0761-8
42. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018–1029. (In Russ). doi: 10.26442/004036
43. Buzunov RV, Palman AD, Melnikov AYu, et al. Diagnostics and Treatment of Obstructive Sleep Apnea Syndrome in Adults. Recommendations of the Russian Society of Sleep Medicine. Effektivnaya farmakoterapiya. Nevrologiya. Spetsvypusk «Son i ego rasstroistva». 2018;35:34–45. (In Russ).
44. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–821. doi: 10.1097/ALN.0b013e31816d83e4
45. Fudim M, Shahid I, Emani S, et al. Evaluation and treatment of central sleep apnea in patients with heart failure. Curr Probl Cardiol. 2022;47(12):101364. doi: 10.1016/j.cpcardiol.2022.101364
46. Tran NT, Tran HN, Mai AT. A wearable device for at-home obstructive sleep apnea assessment: State-of-the-art and research challenges. Front Neurol. 2023;14:1123227. doi: 10.3389/fneur.2023.1123227
47. Monda VM, Gentile S, Porcellati F, et al. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes. Adv Ther. 2022;39(11):4837–4846. doi: 10.1007/s12325-022-02310-2
48. Buzunov RV. Obesity and Obstructive Sleep Apnea: How to Break the Vicious Circle. Effektivnaya farmakoterapiya. 2020;16(2):30–33. (In Russ).
49. Brulé D, Villano C, Davies LJ, et al. The grapevine (Vitis vinifera) LysM receptor kinases VvLYK1-1 and VvLYK1-2 mediate chitooligosaccharide-triggered immunity. Plant Biotechnol J. 2019;17(4):812–825. doi: 10.1111/pbi.13017
50. Chang HP, Chen YF, Du JK. Obstructive sleep apnea treatment in adults. Kaohsiung J Med Sci. 2020;36(1):7–12. doi: 10.1002/kjm2.12130
51. Gorbunova MV, Babak SL, Malyavin AG. Modern algorithm for the diagnosis and treatment of cardiovascular and metabolic disorders in patients with obstructive sleep apnea. Lechebnoe Delo. 2019. № 1. (In Russ). doi: 10.24411/2071-5315-2019-12086
52. Akashiba T, Inoue Y, Uchimura N, et al. Sleep apnea syndrome (SAS) clinical practice guidelines 2020. Respir Investig. 2022;60(1):3–32. doi: 10.1016/j.resinv.2021.08.010
2. Кантимирова Е.А. Современные методы дифференциальной диагностики центрального и обструктивного апноэ сна // Вестник Клинической больницы № 51. 2012. № 1–2. С. 34–37.
3. Рубина С.С., Макарова И.И. Обструктивное апноэ сна: современный взгляд на проблему // Уральский медицинский журнал. 2021. Т. 20, № 4. С. 85–92.
doi: 10.52420/2071-5943-2021-20-4-85-92
4. Arzt M., Woehrle H., Oldenburg O., et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry // JACC Heart Fail. 2016. Vol. 4, N 2. P. 116–125. doi: 10.1016/j.jchf.2015.09.014
5. Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020 // Российский кардиологический журнал. 2020. Т. 25, № 3. С. 3786. doi: 10.15829/1560-4071-2020-3-3786
6. Евлампиева Л.Г., Ярославская Е.И., Харац В.Е. Взаимосвязь синдрома обструктивного апноэ сна и факторов сердечно-сосудистого риска // Сибирский журнал клинической и экспериментальной медицины. 2021. Т. 36, № 1. С. 58–65. doi: 10.29001/2073-8552-2021-36-1-58-65
7. Yeghiazarians Y., Jneid H., Tietjens J.R., et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association // Circulation. 2021. Vol. 144, N 3. P. e56–e67. doi: 10.1161/CIR.0000000000000988. Erratum in: Circulation. 2022. Vol. 145, N 12. P. e775.
8. Warchol-Celinska E., Prejbisz A., Kadziela J., et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial // Hypertension. 2018. Vol. 72, N 2. P. 381–390. doi: 10.1161/HYPERTENSIONAHA.118.11180
9. Johnson D.A., Thomas S.J., Abdalla M., et al. Association Between Sleep Apnea and Blood Pressure Control Among Blacks // Circulation. 2019. Vol. 139, N 10. P. 1275–1284. doi: 10.1161/CIRCULATIONAHA.118.036675
10. Dempsey J.A., Veasey S.C., Morgan B.J., O’Donnell C.P. Pathophysiology of sleep apnea // Physiol Rev. 2010. Vol. 90, N 1. P. 47–112. doi: 10.1152/physrev.00043.2008
11. Kwon Y., Debaty G., Puertas L., et al. Effect of regulating airway pressure on intrathoracic pressure and vital organ perfusion pressure during cardiopulmonary resuscitation: a non-randomized interventional cross-over study // Scand J Trauma Resusc Emerg Med. 2015. N 23. P. 83. doi: 10.1186/s13049-015-0164-5
12. Tolle F.A., Judy W.V., Yu P.L., Markand O.N. Reduced stroke volume related to pleural pressure in obstructive sleep apnea // J Appl Physiol Respir Environ Exerc Physiol. 1983. Vol. 55, N 6. P. 1718–1724. doi: 10.1152/jappl.1983.55.6.1718
13. Somers V.K., Dyken M.E., Clary M.P., Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea // J Clin Invest. 1995. Vol. 96, N 4. P. 1897–904. doi: 10.1172/JCI118235
14. Sforza E., Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach // Hypoxia (Auckl). 2016. N4:. P. 99–108. doi: 10.2147/HP.S10309
15. Arredondo E., Udeani G., Panahi L., et al. Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know // Cureus. 2021. Vol. 13, N 9. P. e17843. doi: 10.7759/cureus.17843
16. Silveira M.G., Sampol G., Mota-Foix M., et al. Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up // J Clin Sleep Med. 2022. Vol. 18, N 2. P. 597–607. doi: 10.5664/jcsm.9674
17. Martinez-Garcia M.A., Capote F., Campos-Rodriguez F., et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial // JAMA. 2013. Vol. 310, N 22. P. 2407–2415. doi: 10.1001/jama.2013.281250
18. Javaheri S., Gottlieb D.J., Quan S.F. Effects of continuous positive airway pressure on blood pressure in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES) // J Sleep Res. 2019. Vol. 29, N 2. P. e12943. doi: 10.1111/jsr.12943
19. Walia H.K., Li H., Rueschman M., et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use // J Clin Sleep Med. 2014. Vol. 10, N 8. P. 835–843. doi: 10.5664/jcsm.3946
20. Deleanu O.C., Oprea C.I., Malaut A.E., et al. Long-term effects of CPAP on blood pressure in non-resistant hypertensive patients with obstructive sleep apnea: A 30 month prospective study // European Respiratory Journal. 2016. N 48. P. PA2082. doi: 10.1183/13993003.congress-2016.PA2082
21. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension // N Engl J Med. 2000. Vol. 342, N 19. P. 1378–1384. doi: 10.1056/NEJM200005113421901
22. O’Connor G.T., Caffo B., Newman A.B., et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study // Am J Respir Crit Care Med. 2009. Vol. 179, N 12. P. 1159–1164. doi: 10.1164/rccm.200712-1809OC
23. Аксенова А.В., Сивакова О.А., Блинова Н.В., и др. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии // Терапевтический архив. 2021. Т. 93, № 9. С. 1018–1029. doi: 10.26442/00403660.2021.09.201007
24. Marin J.M., Agusti A., Villar I., et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension // JAMA. 2012. Vol. 307, N 20. P. 2169–2176. doi: 10.1001/jama.2012.3418
25. Mokhlesi B., Varga A.W. Obstructive Sleep Apnea and Cardiovascular Disease. REM Sleep Matters! // Am J Respir Crit Care Med. 2018. Vol. 197, N 5. P. 554–556. doi: 10.1164/rccm.201710-2147ED
26. Баймуканов А.М., Булавина И.А., Петрова Г.А., и др. Апноэ сна у пациентов с фибрилляцией предсердий // Лечебное дело. 2022. № 2. С. 132–136.
doi: 10.24412/2071-5315-2022-12817
27. Tung P., Levitzky Y.S., Wang R., et al. Obstructive and Central Sleep Apnea and the Risk of Incident Atrial Fibrillation in a Community Cohort of Men and Women // J Am Heart Assoc. 2017. Vol. 6, N 7. P. e004500. doi: 10.1161/JAHA.116.004500
28. Харац В.Е. Проблема ассоциации обструктивного апноэ сна и фибрилляции предсердий в условиях кардиологической практики // Сибирский журнал клинической и экспериментальной медицины. 2022. Т. 37, № 3. С. 41–48. doi: 10.29001/2073-8552-2022-37-3-41-48
29. Остроумова О.Д., Исаев Р.И., Котовская Ю.В., Ткачева О.Н. Влияние лекарственных средств на синдром обструктивного апноэ сна // Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2020. Т. 120, № 9–2. С. 46–54. (In Russ). doi: 10.17116/jnevro202012009146
30. Linz D., McEvoy R.D., Cowie M.R., et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review // JAMA Cardiol. 2018. Vol. 3, N 6. P. 532–540. doi: 10.1001/jamacardio.2018.0095
31. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients // Eur J Heart Failure. 2007. Vol. 9, N 3. P. 251–257. doi: 10.1016/j.ejheart.2006.08.003
32. Sanchez A.M., Germany R., Lozier M.R., et al. Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications // Int J Cardiol Heart Vasc. 2020. N 30. P. 100527. doi: 10.1016/j.ijcha.2020.100527
33. Chen L., Zadi Z.H., Zhang J., et al. Intermittent hypoxia in utero damages postnatal growth and cardiovascular function in rats // J Appl Physiol (1985). 2018. Vol. 124, N 4. P. 821–830. doi: 10.1152/japplphysiol.01066.2016
34. Orban M., Bruce C.J., Pressman G.S., et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure // Am J Cardiol. 2008. Vol. 102, N 11. P. 1557–1561. doi: 10.1016/j.amjcard.2008.07.050
35. Khayat R.N., Abraham W.T., Patt B., et al. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea // Chest. 2008. Vol. 134, N 6. P. 1162–1168. doi: 10.1378/chest.08-0346
36. Javaheri S., Javaheri S. Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions // J Clin Med. 2022. Vol. 11, N12). P. 3458. doi: 10.3390/jcm11123458
37. Gunta S.P., Jakulla R.S., Ubaid A., et al. Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022 // Cardiovasc Ther. 2022. N 2022. P. 6006127. doi: 10.1155/2022/6006127
38. O΄Donnell C., O΄Mahony A.M., McNicholas W.T., Ryan S. Cardiovascular manifestations in obstructive sleep apnea: current evidence and potential mechanisms // Polish Arch Internal Med. 2021. Vol. 131, N 6. P. 550–560. doi: 10.20452/pamw.16041
39. Newman S.B., Kundel V., Matsuzaki M., et al. Sleep apnea, coronary artery calcium density, and cardiovascular events: results from the Multi-Ethnic Study of Atherosclerosis // J Clin Sleep Med. 2021. Vol. 17, N 10. P. 2075–2083. doi: 10.5664/jcsm.9356
40. Mooe T., Franklin K.A., Wiklund U., et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease // Chest. 2000. Vol. 117, N 6. P. 1597–1602. doi: 10.1378/chest.117.6.1597
41. Wang X., Zhang Y., Dong Z., et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis // Respir Res. 2018. Vol. 19, N 1. P. 61. doi: 10.1186/s12931-018-0761-8
42. Аксенова А.В., Сивакова О.А., Блинова Н.В., и др. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии // Терапевтический архив. 2021. Т. 93, № 9. С. 1018–1029. doi: 10.26442/004036
43. Бузунов Р.В., Пальман А.Д., Мельников А.Ю., и др. Диагностика и лечение синдрома обструктивного апноэ сна у взрослых. Рекомендации Российского общества сомнологов // Эффективная фармакотерапия. Неврология. Спецвыпуск «Сон и его расстройства». 2018. № 35. С. 34–45.
44. Chung F., Yegneswaran B., Liao P., et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea // Anesthesiology. 2008. Vol. 108, N 5. P. 812–821. doi: 10.1097/ALN.0b013e31816d83e4
45. Fudim M., Shahid I., Emani S., et al. Evaluation and treatment of central sleep apnea in patients with heart failure // Curr Probl Cardiol. 2022. Vol. 47, N 12. P. 101364. doi: 10.1016/j.cpcardiol.2022.101364
46. Tran N.T., Tran H.N., Mai A.T. A wearable device for at-home obstructive sleep apnea assessment: State-of-the-art and research challenges // Front Neurol. 2023. N 14. P. 1123227. doi: 10.3389/fneur.2023.1123227
47. Monda V.M., Gentile S., Porcellati F., et al. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes // Adv Ther. 2022. Vol. 39, N 11. P. 4837–4846. doi: 10.1007/s12325-022-02310-2
48. Бузунов Р.В. Ожирение и синдром обструктивного апноэ во сне: как разорвать порочный круг // Эффективная фармакотерапия. 2020. Т. 16, № 2. С. 30–33.
49. Brulé D., Villano C., Davies L.J., et al. The grapevine (Vitis vinifera) LysM receptor kinases VvLYK1-1 and VvLYK1-2 mediate chitooligosaccharide-triggered immunity // Plant Biotechnol J. 2019. Vol. 17, N 4. P. 812–825. doi: 10.1111/pbi.13017
50. Chang H.P., Chen Y.F., Du J.K. Obstructive sleep apnea treatment in adults // Kaohsiung J Med Sci. 2020. Vol. 36, N 1. P. 7–12. doi: 10.1002/kjm2.12130
51. Горбунова М.В., Бабак С.Л., Малявин А.Г. Современный алгоритм диагностики и лечения кардиоваскулярных и метаболических нарушений у пациентов с обструктивным апноэ сна // Лечебное дело. 2019. № 1. C. 20–29. doi: 10.24411/2071-5315-2019-12086
52. Akashiba T., Inoue Y., Uchimura N., et al. Sleep apnea syndrome (SAS) clinical practice guidelines 2020 // Respir Investig. 2022. Vol. 60, N 1. P. 3–32. doi: 10.1016/j.resinv.2021.08.010
________________________________________________
2. Kantimirova EA. Modern methods of differential diagnosis of central and obstructive sleep apnea. Vestnik Klinicheskoi bol'nitsy № 51. 2012;1–2:34–37. (In Russ).
3. Rubina SS, Makarova II. Obstructive sleep apnea: a modern view of the problem. Ural Medical Journal. 2021;20(4):85–92. (In Russ). doi: 10.52420/2071-5943-2021-20-4-85-92
4. Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail. 2016;4(2):116–125. doi: 10.1016/j.jchf.2015.09.014
5. Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ).
doi: 10.15829/1560-4071-2020-3-3786
6. Evlampieva LG, Yaroslavskaya EI, Kharats VE. Relationships between obstructive sleep apnea syndrome and cardiovascular risk factors. The Siberian Journal of Clinical and Experimental Medicine. 2021;36(1):58–65. (In Russ). doi: 10.29001/2073-8552-2021-36-1-58-65
7. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56–e67. doi: 10.1161/CIR.0000000000000988. Erratum in: Circulation. 2022;145(12):e775.
8. Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal Denervation in Resistant Hypertension and Obstructive Sleep Apnea: Randomized Proof-of-Concept Phase II Trial. Hypertension. 2018;72(2):381–390. doi: 10.1161/HYPERTENSIONAHA.118.11180
9. Johnson DA, Thomas SJ, Abdalla M, et al. Association Between Sleep Apnea and Blood Pressure Control Among Blacks. Circulation. 2019;139(10):1275–1284. doi: 10.1161/CIRCULATIONAHA.118.036675
10. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47–112. doi: 10.1152/physrev.00043.2008
11. Kwon Y, Debaty G, Puertas L, et al. Effect of regulating airway pressure on intrathoracic pressure and vital organ perfusion pressure during cardiopulmonary resuscitation: a non-randomized interventional cross-over study. Scand J Trauma Resusc Emerg Med. 2015;23:83. doi: 10.1186/s13049-015-0164-5
12. Tolle FA, Judy WV, Yu PL, Markand ON. Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(6):1718–1724. doi: 10.1152/jappl.1983.55.6.1718
13. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897–904. doi: 10.1172/JCI118235
14. Sforza E, Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach. Hypoxia (Auckl). 2016;4:99–108. doi: 10.2147/HP.S10309
15. Arredondo E, Udeani G, Panahi L, et al. Obstructive Sleep Apnea in Adults: What Primary Care Physicians Need to Know. Cureus. 2021;13(9):e17843. doi: 10.7759/cureus.17843
16. Silveira MG, Sampol G, Mota-Foix M, et al. Cluster-derived obstructive sleep apnea phenotypes and outcomes at 5-year follow-up. J Clin Sleep Med. 2022;18(2):597–607. doi: 10.5664/jcsm.9674
17. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310(22):2407–2415. doi: 10.1001/jama.2013.281250
18. Javaheri S, Gottlieb DJ, Quan SF. Effects of continuous positive airway pressure on blood pressure in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). J Sleep Res. 2019;29(2):e12943. doi: 10.1111/jsr.12943
19. Walia HK, Li H, Rueschman M, et al. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. J Clin Sleep Med. 2014;10(8):835–843. doi: 10.5664/jcsm.3946
20. Deleanu OC, Oprea CI, Malaut AE, et al. Long-term effects of CPAP on blood pressure in non-resistant hypertensive patients with obstructive sleep apnea: A 30 month prospective study. European Respiratory Journal. 2016;48:PA2082. doi: 10.1183/13993003.congress-2016.PA2082
21. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384. doi: 10.1056/NEJM200005113421901
22. O’Connor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179(12):1159–1164. doi: 10.1164/rccm.200712-1809OC
23. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018–1029. (In Russ). doi: 10.26442/00403660.2021.09.201007
24. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169–2176. doi: 10.1001/jama.2012.3418
25. Mokhlesi B, Varga AW. Obstructive Sleep Apnea and Cardiovascular Disease. REM Sleep Matters! Am J Respir Crit Care Med. 2018;197(5):554–556.
doi: 10.1164/rccm.201710-2147ED
26. Baimukanov AM, Bulavina IA, Petrova GA, et al. Sleep apnea in patients with atrial fibrillation. Lechebnoe Delo. 2022;2:132–136. (In Russ). doi: 10.24412/2071-5315-2022-12817
27. Tung P, Levitzky YS, Wang R, et al. Obstructive and Central Sleep Apnea and the Risk of Incident Atrial Fibrillation in a Community Cohort of Men and Women. J Am Heart Assoc. 2017;6(7):e004500. doi: 10.1161/JAHA.116.004500
28. Kharats VE. The problem of association between obstructive sleep apnea and atrial fibrillation in cardiology practice. The Siberian Journal of Clinical and Experimental Medicine. 2022;37(3):41–48. (In Russ). doi: 10.29001/2073-8552-2022-37-3-41-48
29. Ostroumova OD, Isaev RI, Kotovskaya YV, Tkacheva ON. Drugs affecting obstructive sleep apnea syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(9–2):46–54. (In Russ). doi: 10.17116/jnevro202012009146
30. Linz D, McEvoy RD, Cowie MR, et al. Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review. JAMA Cardiol. 2018;3(6):532–540. doi: 10.1001/jamacardio.2018.0095
31. Oldenburg O, Lamp B, Faber L, et al. Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Failure. 2007;9(3):251–257. doi: 10.1016/j.ejheart.2006.08.003
32. Sanchez AM, Germany R, Lozier MR, et al. Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications. Int J Cardiol Heart Vasc. 2020;30:100527. doi: 10.1016/j.ijcha.2020.100527
33. Chen L, Zadi ZH, Zhang J, et al. Intermittent hypoxia in utero damages postnatal growth and cardiovascular function in rats. J Appl Physiol (1985). 2018;124(4):821–830. doi: 10.1152/japplphysiol.01066.2016
34. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102(11):1557–1561. doi: 10.1016/j.amjcard.2008.07.050
35. Khayat RN, Abraham WT, Patt B, et al. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea. Chest. 2008;134(6):1162–1168. doi: 10.1378/chest.08-0346
36. Javaheri S, Javaheri S. Obstructive Sleep Apnea in Heart Failure: Current Knowledge and Future Directions. J Clin Med. 2022;11(12):3458. doi: 10.3390/jcm11123458
37. Gunta SP, Jakulla RS, Ubaid A, et al. Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022. Cardiovasc Ther. 2022;2022:6006127. doi: 10.1155/2022/6006127
38. O΄Donnell C, O΄Mahony AM, McNicholas WT, Ryan S. Cardiovascular manifestations in obstructive sleep apnea: current evidence and potential mechanisms. Polish Arch Internal Med. 2021;131(6):550–560. doi: 10.20452/pamw.16041
39. Newman SB, Kundel V, Matsuzaki M, et al. Sleep apnea, coronary artery calcium density, and cardiovascular events: results from the Multi-Ethnic Study of Atherosclerosis. J Clin Sleep Med. 2021;17(10):2075–2083. doi: 10.5664/jcsm.9356
40. Mooe T, Franklin KA, Wiklund U, et al. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest. 2000;117(6):1597–1602. doi: 10.1378/chest.117.6.1597
41. Wang X, Zhang Y, Dong Z, et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis. Respir Res. 2018;19(1):61. doi: 10.1186/s12931-018-0761-8
42. Aksenova AV, Sivakova OA, Blinova NV, et al. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii arkhiv. 2021;93(9):1018–1029. (In Russ). doi: 10.26442/004036
43. Buzunov RV, Palman AD, Melnikov AYu, et al. Diagnostics and Treatment of Obstructive Sleep Apnea Syndrome in Adults. Recommendations of the Russian Society of Sleep Medicine. Effektivnaya farmakoterapiya. Nevrologiya. Spetsvypusk «Son i ego rasstroistva». 2018;35:34–45. (In Russ).
44. Chung F, Yegneswaran B, Liao P, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108(5):812–821. doi: 10.1097/ALN.0b013e31816d83e4
45. Fudim M, Shahid I, Emani S, et al. Evaluation and treatment of central sleep apnea in patients with heart failure. Curr Probl Cardiol. 2022;47(12):101364. doi: 10.1016/j.cpcardiol.2022.101364
46. Tran NT, Tran HN, Mai AT. A wearable device for at-home obstructive sleep apnea assessment: State-of-the-art and research challenges. Front Neurol. 2023;14:1123227. doi: 10.3389/fneur.2023.1123227
47. Monda VM, Gentile S, Porcellati F, et al. Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes. Adv Ther. 2022;39(11):4837–4846. doi: 10.1007/s12325-022-02310-2
48. Buzunov RV. Obesity and Obstructive Sleep Apnea: How to Break the Vicious Circle. Effektivnaya farmakoterapiya. 2020;16(2):30–33. (In Russ).
49. Brulé D, Villano C, Davies LJ, et al. The grapevine (Vitis vinifera) LysM receptor kinases VvLYK1-1 and VvLYK1-2 mediate chitooligosaccharide-triggered immunity. Plant Biotechnol J. 2019;17(4):812–825. doi: 10.1111/pbi.13017
50. Chang HP, Chen YF, Du JK. Obstructive sleep apnea treatment in adults. Kaohsiung J Med Sci. 2020;36(1):7–12. doi: 10.1002/kjm2.12130
51. Gorbunova MV, Babak SL, Malyavin AG. Modern algorithm for the diagnosis and treatment of cardiovascular and metabolic disorders in patients with obstructive sleep apnea. Lechebnoe Delo. 2019. № 1. (In Russ). doi: 10.24411/2071-5315-2019-12086
52. Akashiba T, Inoue Y, Uchimura N, et al. Sleep apnea syndrome (SAS) clinical practice guidelines 2020. Respir Investig. 2022;60(1):3–32. doi: 10.1016/j.resinv.2021.08.010
Авторы
Н.А. Сурикова*1, А.С. Глухова2
1 Оренбургский государственный медицинский университет, Оренбург, Российская Федерация
2 Городская Покровская больница, Санкт-Петербург, Российская Федерация
*nina70494@mail.ru
1 Orenburg State Medical University, Orenburg, Russian Federation
2 Pokrovskaya City Hospital, St. Petersburg, Russian Federation
*nina70494@mail.ru
1 Оренбургский государственный медицинский университет, Оренбург, Российская Федерация
2 Городская Покровская больница, Санкт-Петербург, Российская Федерация
*nina70494@mail.ru
________________________________________________
1 Orenburg State Medical University, Orenburg, Russian Federation
2 Pokrovskaya City Hospital, St. Petersburg, Russian Federation
*nina70494@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.